The Ancure endografting system: an update - PubMed
The Ancure endografting system (Guidant Cardiac and Vascular Division, Menlo Park, Calif) features a unibody, nonsupported woven polyester graft designed to treat abdominal aortic …
三类医疗血管设备-覆膜支架、腔内移植物、胸主动脉覆膜支架 - 知乎
Ancure设备是一种主体直径为 26 mm 的一体式无支撑编织聚酯腔内移植物（Guidant Corp.，St. Paul，Minn）（图 9）。 这种腔内移植物适用于主动脉颈直径为 18 至 26 毫米且颈长大于 15 …
The ANCURE Aortoiliac System is indicated for the endovascular treatment of infrarenal abdominal aortic aneurysms or aortoiliac aneurysms (AAA) in patients whose anatomy does …
The Ancure endografting system (Guidant Cardiac and Vascular Division, Menlo Park, Calif) features a unibody, non-supported woven polyester graft designed to treat abdominal aortic …
The Ancure endografting system: An update - Journal of Vascular …
The Ancure endografting system (Guidant Cardiac and Vascular Division, Menlo Park, Calif) features a unibody, nonsupported woven polyester graft designed to treat abdominal aortic …
The Next Generation of Aortic Endografts - Endovascular Today
The Ancure graft was a conservative design that preserved most of the characteristics of an open surgical graft reconstruction by using a unibody bifurcated polyester graft without stent support …
The Ancure endografting system: an update. | Semantic Scholar
2001年2月1日 · The Ancure endografting system is a unibody, nonsupported woven polyester graft designed to treat abdominal aortic aneurysms that was deployed successfully in 90% to …
The Guidant Ancure bifurcation endograft: five-year follow-up
Endovascular repair of an abdominal aortic aneurysm using a Guidant bifurcated graft resulted in a statistically significant reduction of perioperative morbidity, was conserving of hospital …
一项对Guidant公司 ANCURE 支架的三年临床研究显示有效控制腹 …
2000年11月1日 · 一项为期三年关于Guidant公司生产的治疗腹主动脉瘤(AAA) ANCURE(TM)支架的临床研究显示，ANCURE 支架能持续缩小大部分患者（75%）动脉瘤的直径。这项研究 …
Endotension after endovascular aneurysm repair: The Ancure …
2001年9月1日 · Methods: The core laboratory imaging database from the Ancure (Guidant) endovascular graft Phase I and Phase II trials approved by the Food and Drug Administration …